Cost-benefit analysis in partnership with Eradigm: Hearing intervention and reducing the risk of dementia
This initiative, a collaborative effort with Eradigm, delves into a detailed cost-benefit analysis of hearing interventions, emphasizing their potential in mitigating the risk of dementia. Building on evidence that suggests a link between hearing aid usage and slowed cognitive decline, the project aims to quantify the economic and health benefits of early intervention in hearing loss.
By exploring the financial and care implications of this modifiable risk factor, the project aims to highlight the significant savings in healthcare costs and the improvement in life quality for individuals with hearing impairments. It represents a innovative approach to public health, advocating for hearing health as a pivotal aspect of dementia prevention strategies.
For a more information, please reach out to brainworks@gnhearing.com
Listen To This™ is a trademark of GN Group
